Ivermectin prophylaxis for Covid-19 Infection in Health care Personnel
Phase 4
- Registration Number
- CTRI/2021/03/031665
- Lead Sponsor
- AIIMS Rishikesh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Health care personnel (HCP) >18 years age
2.HCP identified as primary contact and have High Risk defined as per ICMR guidelines for contracting COVID-19 infection
3.HCP who have not presented with general symptoms such as general discomfort, fever, cough, dyspnoea or muscle pain in the last week.
4.HCP who are willing to give written informed consent
Exclusion Criteria
1.Already infected with SARS-cov-2/ previous COVID-19 within the last 6 months
2.HCW who have taken any medication as possible prophylaxis for COVID-19
3.Pregnancy
4.Prior enrolment into this or other COVID-19 prevention or treatment trials.
5.HCW with known allergy to ivermectin
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method RT- Polymerase chain reaction (PCR) confirmed SARS-CoV-2 infection [ Day 10]- As per State covid management guidelinesTimepoint: Day 10
- Secondary Outcome Measures
Name Time Method Development of Symptoms ( Fever ,Cough, Sore Throat, Myalgia, Diarrhea, Shortness of Breath) [ within 14 days after enrolment ]Timepoint: 14 day